Page 1 | Search Results | Blood | American Society of Hematology

1-9 of 9

Sort by

Sort Order Select

Journal Articles

The effect of variation in donor platelet function on transfusion outcome: a semirandomized controlled trial

Anne M. Kelly, Stephen F. Garner, Theodora Foukaneli, Thomas R. Godec, Nina Herbert, Brennan C. Kahan, Alison Deary, Lekha Bakrania, Charlotte Llewelyn, Willem H. Ouwehand, Lorna M. Williamson, Rebecca A. Cardigan

Blood (2017) 130 (2): 214–220.

https://doi.org/10.1182/blood-2017-01-759258

Published: 2017

Includes: Supplemental data

Journal Articles

Recombinant HPA-1a antibody therapy for treatment of fetomaternal alloimmune thrombocytopenia: proof of principle in human volunteers

Cedric Ghevaert, Nina Herbert, Louise Hawkins, Nicola Grehan, Philip Cookson, Steve F. Garner, Abigail Crisp-Hihn, Paul Lloyd-Evans, Amanda Evans, Kottekkattu Balan, Willem H. Ouwehand, Kathryn L. Armour, Mike R. Clark, Lorna M. Williamson

Blood (2013) 122 (3): 313–320.

https://doi.org/10.1182/blood-2013-02-481887

Published: 2013

Includes: Supplemental data

Journal Articles

Pre-Operative Transfusion Reduces Serious Adverse Events in Patients with Sickle Cell Disease (SCD): Results From the Transfusion Alternatives Preoperatively in Sickle Cell Disease (TAPS) Randomised Controlled Multicentre Clinical Trial

Jo Howard, MB, BChir, MRCP, FRCPath, Moira Malfroy, RN, Llewelyn Charlotte, PhD, Louise Choo, PhD, David Rees, FRCPath, Isabeau Walker, FRCA, Tony Johnson, PhD, Louise Tillyer, FRCPath, Karin Fijnvandraat, MD, PhD, Melanie Kirby-Allen, MD, Renate Hodge, MSc, Shilpi Purohit, Sally C. Davies, FRCP, FMedSci, Lorna M Williamson, FRCPath

Blood (2011) 118 (21): 9.

https://doi.org/10.1182/blood.V118.21.9.9

Published: 2011

Journal Articles

Recombinant Human HPA-1A Antibodies for Treatment of Fetomaternal Alloimmune Thrombocytopenia (FMAIT): Proof of Principle in An in Vivo Murine Model and Human Volunteer Studies

Cedric Ghevaert, David A. Wilcox, PhD, Juan Fang, Kathryn Armour, Mike R Clark, Willem H. Ouwehand, Lorna M Williamson

Blood (2008) 112 (11): 85.

https://doi.org/10.1182/blood.V112.11.85.85

Published: 2008

Journal Articles

Intravascular survival of red cells coated with a mutated human anti-D antibody engineered to lack destructive activity

Kathryn L. Armour, David R. Parry-Jones, Nigel Beharry, James R. Ballinger, Rosey Mushens, R. Keith Williams, Cynthia Beatty, Simon Stanworth, Paul Lloyd-Evans, Marion Scott, Michael R. Clark, A. Michael Peters, Lorna M. Williamson

Blood (2006) 107 (7): 2619–2626.

https://doi.org/10.1182/blood-2005-03-0989

Published: 2006

Journal Articles

Assessment of removal of human cytomegalovirus from blood components by leukocyte depletion filters using real-time quantitative PCR

Micaela Rios Visconti, Joanne Pennington, Stephen F. Garner, Jean-Pierre Allain, Lorna M. Williamson

Blood (2004) 103 (3): 1137–1139.

https://doi.org/10.1182/blood-2003-03-0762

Published: 2004

Journal Articles

The low-frequency allele of the platelet collagen signaling receptor glycoprotein VI is associated with reduced functional responses and expression

Lotta Joutsi-Korhonen, Peter A. Smethurst, Angela Rankin, Elaine Gray, Martin IJsseldijk, Catherine M. Onley, Nicholas A. Watkins, Lorna M. Williamson, Alison H. Goodall, Philip G. de Groot, Richard W. Farndale, Willem H. Ouwehand

Blood (2003) 101 (11): 4372–4379.

https://doi.org/10.1182/blood-2002-08-2591

Published: 2003

Journal Articles

Persistence of HTLV-I in blood components after leukocyte depletion

Joanne Pennington, Graham P. Taylor, Janet Sutherland, Ricardo E. Davis, Jerhard Seghatchian, Jean-Pierre Allain, Lorna M. Williamson

Blood (2002) 100 (2): 677–681.

https://doi.org/10.1182/blood.V100.2.677

Published: 2002

Journal Articles

The Natural History of Fetomaternal Alloimmunization to the Platelet-Specific Antigen HPA-1a (Pl A1 , Zw a ) as Determined by Antenatal Screening

Lorna M. Williamson, Gerald Hackett, Janet Rennie, Christopher R. Palmer, Caroline Maciver, Ruth Hadfield, Darren Hughes, Shirley Jobson, Willem H. Ouwehand

Blood (1998) 92 (7): 2280–2287.

https://doi.org/10.1182/blood.V92.7.2280

Published: 1998

NARROW

The effect of variation in donor platelet function on transfusion outcome: a semirandomized controlled trial

Recombinant HPA-1a antibody therapy for treatment of fetomaternal alloimmune thrombocytopenia: proof of principle in human volunteers

Pre-Operative Transfusion Reduces Serious Adverse Events in Patients with Sickle Cell Disease (SCD): Results From the Transfusion Alternatives Preoperatively in Sickle Cell Disease (TAPS) Randomised Controlled Multicentre Clinical Trial

Recombinant Human HPA-1A Antibodies for Treatment of Fetomaternal Alloimmune Thrombocytopenia (FMAIT): Proof of Principle in An in Vivo Murine Model and Human Volunteer Studies

Intravascular survival of red cells coated with a mutated human anti-D antibody engineered to lack destructive activity

Assessment of removal of human cytomegalovirus from blood components by leukocyte depletion filters using real-time quantitative PCR

The low-frequency allele of the platelet collagen signaling receptor glycoprotein VI is associated with reduced functional responses and expression

Persistence of HTLV-I in blood components after leukocyte depletion

The Natural History of Fetomaternal Alloimmunization to the Platelet-Specific Antigen HPA-1a (Pl A1 , Zw a ) as Determined by Antenatal Screening

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only